A method and application for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression

By interfering with HNRNPAB expression and using siRNA to reduce HNRNPAB expression in bovine skeletal muscle satellite cells, the myogenic differentiation of bovine skeletal muscle satellite cells was promoted. This solved the problem of unclear role of HNRNPAB in the myogenic differentiation of bovine skeletal muscle satellite cells, and achieved effective regulation of muscle development and improvement of meat production performance.

CN115976111BActive Publication Date: 2024-11-05TIANJIN AGRICULTURE COLLEGE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210792826.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-07
Publication Date
2024-11-05
Estimated Expiration
2042-07-07

AI Technical Summary

Technical Problem

The role of HNRNPAB in the myogenic differentiation of bovine skeletal muscle satellite cells is unclear in the existing technology, making it difficult to effectively promote the proliferation and myogenic differentiation of bovine skeletal muscle satellite cells.

Method used

By designing and synthesizing HNRNPAB siRNA, the expression level of HNRNPAB in bovine skeletal muscle satellite cells was reduced. The expression of HNRNPAB was then interfered with by siRNA transfection or by using plasmids, viral vectors, etc., thereby promoting myogenic differentiation of bovine skeletal muscle satellite cells.

Benefits of technology

Effectively regulating the proliferation and myogenic differentiation of bovine skeletal muscle satellite cells provides new research ideas and methods for muscle development, differentiation, and damage repair, thereby improving beef yield and quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115976111B_ABST
    Figure CN115976111B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of biology, cell and tissue engineering technology, and discloses a method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression, wherein the method promotes myogenic differentiation of bovine skeletal muscle satellite cells by reducing the expression of HNRNPAB; wherein the nucleotide sequence of the HNRNPAB gene is: SEQ ID NO.1. The method of the present invention regulates the proliferation and myogenic differentiation process of bovine muscle satellite cells by changing the expression of HNRNPAB, which can provide inspiration for the study of muscle development and differentiation process, and provide reference for exploring the mechanism of muscle growth and development and improving the yield and quality of beef.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the fields of biotechnology, cell and tissue engineering technology, and in particular to a method and application of promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression. Background Art

[0002] Animal muscle development includes two aspects: proliferation and hypertrophy of muscle fibers during the embryonic period and after birth. It is a long-term biological process and is regulated by many genes. Skeletal muscle is an important component of muscle. It exists in various tissues of organisms and is an indispensable component of physiological processes such as respiration and metabolism. The growth and development of skeletal muscle is accompanied by the joint regulation of many genes. Skeletal muscle satellite cells are myogenic stem cells. When the animal body is damaged, they can proliferate and differentiate into new muscle fibers and form new muscle tissue. In the process of animal husbandry, the meat production performance of animals is one of the important factors that determine economic indicators. Studying the muscle growth and development regulatory network from different levels will help understand and improve the meat production performance of animals.

[0003] Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a type of nuclear protein produced by RNA polymerase II and bound to transcripts. They are a type of RNA binding protein involved in a variety of important life activities. There are more than 20 members of the HNRNPs family, named from A to U according to molecular weight. The main members of the family include hnRNPA, hnRNPA / B, hnRNPC, etc. The biological functions of hnRNPs are relatively extensive. It can use its own unique structure to bind to pre-mRNA and participate in the regulation of mRNA splicing, translation, mRNA stability and transcription in the form of a complex of the two. There are also a small number of unnamed members that are responsible for assisting other hnRNPs to complete some biological functions because they are less expressed and do not have the ability to bind to pre-mRNA. hnRNP proteins can undergo post-translational modifications, thereby changing biological activity and subcellular localization. It also plays an important role in the regulation of gene expression. Studies have shown that many hnRNPs are involved in the occurrence and metastasis of cancer. HNRNPAB, as the core protein of the hnRNPs family, is composed of two RNA recognition motifs, an RGG box and two auxiliary regions rich in glycine domains. The RNA recognition motif is composed of about 90-100 amino acids, which can bind to the 3' untranslated (3'UTR) region of Pre-mRNA, and the glycine-rich region plays an important role in nuclear localization function. HNRNPAB is mainly involved in regulating processes such as mRNA transport, metabolism and shearing in biological functions, and has a close relationship with the occurrence and development of many malignant tumors. However, there are few reports on the study of HNRNPAB's participation in animal skeletal muscle development. Based on this, the present invention utilizes a bovine skeletal muscle satellite cell in vitro induced myogenic differentiation model, and by interfering with the expression of HNRNPAB in bovine skeletal muscle satellite cells, studies the effect of HNRNPAB on the in vitro myogenic differentiation of bovine skeletal muscle satellite cells, and lays a certain foundation for further excavating genes that affect bovine muscle development.

[0004] Through searching, no patent publication documents related to the patent application of the present invention have been found. Summary of the invention

[0005] The purpose of the present invention is to overcome the deficiencies in the prior art and provide a method and application for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression.

[0006] The technical solution adopted by the present invention to solve its technical problem is:

[0007] A method for promoting the myogenic differentiation of bovine skeletal muscle satellite cells by interfering with the expression of HNRNPAB, wherein the method promotes the myogenic differentiation of bovine skeletal muscle satellite cells by reducing the expression of HNRNPAB; wherein the nucleotide sequence of the HNRNPAB gene is: SEQ ID NO.1.

[0008] Further, the following steps are included:

[0009] According to the genomic base sequence of HNRNPAB, siRNA of HNRNPAB was designed and synthesized, and bovine skeletal muscle satellite cells were transfected with siRNA to reduce the expression level of HNRNPAB, thereby promoting the myogenic differentiation of bovine skeletal muscle satellite cells.

[0010] Furthermore, the gene sequence of the siRNA is: SEQ ID NO.2.

[0011] Furthermore, the method of interfering with the expression level of HNRNPAB includes: using a plasmid, a viral vector or gene knockout that interferes with the expression of HNRNPAB.

[0012] Application of the method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression as described above in the proliferation and myogenic differentiation of bovine muscle satellite cells.

[0013] The advantages and positive effects achieved by the present invention are:

[0014] 1. The method of the present invention regulates the proliferation and myogenic differentiation process of bovine muscle satellite cells by changing the expression of HNRNPAB, which can provide inspiration for the study of muscle development and differentiation process, and provide a reference for exploring the mechanism of muscle growth and development and improving the yield and quality of beef.

[0015] 2. The method established by the present invention for promoting the proliferation and myogenic differentiation of bovine skeletal muscle satellite cells by changing the expression of HNRNPAB can effectively regulate the muscle development and differentiation process. This method can provide a certain reference for the use of HNRNPAB in muscle development and differentiation and injury repair, and provide new ideas and references for the clinical research and diagnosis and treatment of muscle development and differentiation and injury repair.

[0016] 3. In view of the fact that it is still unclear whether HNRNPAB has a certain regulatory effect on bovine skeletal muscle satellite cells and the specific effect, the present invention designs and synthesizes HNRNPAB siRNA, and then uses lip3000 reagent to transfect bovine skeletal muscle satellite cells, interferes with the expression level of HNRNPAB in bovine skeletal muscle satellite cells, and promotes the proliferation and myogenic differentiation of bovine skeletal muscle satellite cells by changing the expression of HNRNPAB in bovine skeletal muscle satellite cells. This method can provide a reference for the use of HNRNPAB in muscle development, differentiation and injury repair, and provide new ideas and methods for clinical research and diagnosis and treatment of muscle development, differentiation and injury repair.

[0017] 4. The method of the present invention can provide inspiration for the study of skeletal muscle development and differentiation and hnRNPs, lay a good foundation for further research on the mechanism of action of key hnRNPs proteins in muscle development, and provide a theoretical basis for the rapid breeding of new high-quality beef cattle breeds and improvement of meat quality. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 The quantitative PCR and Western blot detection result diagrams of the expression level changes of HNRNPAB in bovine skeletal muscle satellite cells before and after myogenic differentiation in the present invention; wherein, A is a diagram of the mRNA expression level of HNRNPAB detected by qRT-PCR in the proliferation and differentiation stages of bovine skeletal muscle satellite cells, B is a diagram of the protein expression level of HNRNPAB detected by Western blot in the proliferation and differentiation stages of bovine skeletal muscle satellite cells, and C is an intuitive schematic diagram of Western blot detection; wherein, GM is the proliferation stage of bovine skeletal muscle satellite cells, DM1 is the first day of differentiation of bovine skeletal muscle satellite cells, DM2 is the second day of differentiation of bovine skeletal muscle satellite cells, and DM3 is the third day of differentiation of bovine skeletal muscle satellite cells;

[0019] Figure 2 The qRT-PCR detection results of the differentiation marker genes MyoG and MyHC in bovine skeletal muscle satellite cells by using siRNA to interfere with HNRNPAB expression in the present invention; wherein A is a graph of the mRNA expression levels of MyoG and MyHC on the first day of differentiation (DM1), and B is a graph of the mRNA expression levels of MyoG and MyHC on the third day of differentiation (DM3);

[0020] Figure 3The figure is a graph showing the results of Western blot detection of the differentiation marker genes MyoG and MyHC in bovine skeletal muscle satellite cells on the third day (DM3) of differentiation induction by using siRNA to interfere with HNRNPAB expression in the present invention; wherein A is a graph showing the expression levels of MyoG and MyHC proteins after Western blot detection interference, and B is a visual schematic diagram of Western blot detection.

[0021] Figure 4 This is a picture of myotubes observed under an inverted microscope on the third day of differentiation induction after siRNA was used to interfere with HNRNPAB expression in the present invention (200×). DETAILED DESCRIPTION

[0022] The embodiments of the present invention are described in detail below. It should be noted that the embodiments are descriptive rather than restrictive and cannot be used to limit the protection scope of the present invention.

[0023] The raw materials used in the present invention, unless otherwise specified, are conventional commercially available products; the methods used in the present invention, unless otherwise specified, are conventional methods in the art.

[0024] A method for promoting the myogenic differentiation of bovine skeletal muscle satellite cells by interfering with the expression of HNRNPAB, wherein the method promotes the myogenic differentiation of bovine skeletal muscle satellite cells by reducing the expression of HNRNPAB; wherein the nucleotide sequence of the HNRNPAB gene is: SEQ ID NO.1.

[0025] Preferably, the method comprises the following steps:

[0026] According to the genomic base sequence of HNRNPAB, siRNA of HNRNPAB was designed and synthesized, and bovine skeletal muscle satellite cells were transfected with siRNA to reduce the expression level of HNRNPAB, thereby promoting the myogenic differentiation of bovine skeletal muscle satellite cells.

[0027] Preferably, the gene sequence of the siRNA is: SEQ ID NO.2.

[0028] Preferably, the method of interfering with the expression level of HNRNPAB includes: using a plasmid, a viral vector or gene knockout that interferes with the expression of HNRNPAB.

[0029] Application of the method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression as described above in the proliferation and myogenic differentiation of bovine muscle satellite cells.

[0030] Specifically, the relevant preparation and detection examples are as follows:

[0031] A design idea of ​​the present invention may be:

[0032] HNRNPAB siRNA was designed and synthesized, and then the bovine skeletal muscle satellite cells were transfected with lip3000 reagent to interfere with the expression level of HNRNPAB in the bovine skeletal muscle satellite cells. By changing the expression of HNRNPAB in the bovine skeletal muscle satellite cells, the myogenic differentiation process of the bovine skeletal muscle satellite cells was promoted.

[0033] A method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression, comprising the following steps:

[0034] Step 1: Isolation and culture of bovine skeletal muscle satellite cells, establishment of in vitro myogenic differentiation model, and detection of HNRNPAB expression before and after myogenic differentiation of muscle satellite cells:

[0035] The bovine skeletal muscle satellite cells were isolated by the combined digestion of trypsin and collagenase, and the in vitro myogenic differentiation model of bovine skeletal muscle satellite cells was established. The expression of HNRNPAB before and after myogenic differentiation of bovine skeletal muscle satellite cells was detected by quantitative PCR and Western blot.

[0036] The specific steps are as follows:

[0037] (1) Isolation and culture of bovine skeletal muscle satellite cells and establishment of an in vitro myogenic differentiation model.

[0038] Bovine skeletal muscle satellite cells were isolated by combined digestion with trypsin and collagenase. Bovine fetal hind limb muscles were collected under sterile conditions, cut into appropriate sizes, washed several times in PBS buffer, and fully minced with ophthalmic scissors in a culture dish. After rinsing once with preheated PBS buffer, centrifuged at 1000r / min for 5 minutes in a centrifuge, the supernatant was discarded, 5ml of 0.2% collagenase II was added, and digested in a 37℃ water bath for 1h. During this period, vortex oscillation was performed for 10s every 10min, and then 0.25% trypsin containing EDTA was added for digestion for 30min. During this period, Vortex and oscillate for 10s every 10min, and finally add medium containing 20% ​​fetal bovine serum (20% FBS + 80% DMEM) to terminate digestion. The above mixture is passed through 100 mesh, 200 mesh and 400 mesh cell sieves in turn, and the filtrate is collected in a 50ml centrifuge tube, centrifuged at 1000r / min for 10min in a centrifuge, resuspended with medium (20% FBS + 80% DMEM), inoculated into a suitable culture dish, and cultured in a 37°C, 5% CO2 incubator. Cultured in DMEM growth medium containing 20% ​​fetal bovine serum, when the cells grow to 80% confluence, add DMEM differentiation medium containing 2% horse serum, perform in vitro myogenic differentiation, observe the differentiation of muscle satellite cells and the state of myotube formation, and establish an in vitro myogenic differentiation model of bovine skeletal muscle satellite cells.

[0039] (2) HNRNPAB genomic base sequence (1648 bp): SEQ ID NO.1

[0040]

[0041] (3) Detection of changes in HNRNPAB expression before and after myogenic differentiation of bovine skeletal muscle satellite cells.

[0042] Total RNA of proliferating and differentiated cells was extracted using a cell RNA rapid extraction kit. Extraction steps: Add 600mL of cell lysis buffer to a 24-well cell culture plate and repeatedly pipette until the cells are fully lysed. After observing that the cells are completely lysed under a microscope, collect the above lysate into a 1.5mL RNase-free tube. Add all the lysis mixture to the DNA cleanup column. Immediately centrifuge at 13,000rpm for 60s. Use a micropipette to accurately estimate the volume of the filtrate, add an equal volume of 70% ethanol, and immediately pipette to mix, without centrifugation. Immediately add the mixture to an adsorption column RA, centrifuge at 13,000rpm for 30s, and discard the waste liquid. Add 700μL of deproteinization solution RW1, leave at room temperature for 1 minute, centrifuge at 12,000rpm for 30s, and discard the waste liquid. Add 500mL of rinsing solution RW, centrifuge at 12,000rpm for 30s, and discard the waste liquid. Add 500mL of rinsing solution RW and repeat. Put the adsorption column RA back into the empty collection, centrifuge at 13000rpm for 2 minutes, and try to remove the rinse solution to prevent the residual ethanol in the rinse solution from inhibiting the downstream reaction. Take out the adsorption column RA and put it into an enzyme-free centrifuge tube. Add 30-50mL of enzyme-free water to the middle part of the adsorption membrane according to the expected RNA yield, leave it at room temperature for 1 minute, and centrifuge it at 12000rpm for 1 minute.

[0043] The reverse transcription and quantitative PCR of RNA were performed according to the instructions of the kit. The primer sequences used are shown in Table 1, and GAPDH was used as an internal reference. The reverse transcription and quantitative PCR operating conditions of RNA were as follows:

[0044] ①RNA reverse transcription system and conditions:

[0045]

[0046] Prepare a 20 μL mixed solution.

[0047] Vortex to mix, centrifuge briefly, and collect the solution on the tube wall to the bottom of the PCR tube.

[0048] Place the prepared mixture on the PCR instrument and set the program: incubate at 42°C for 15 minutes, then incubate at 85°C for 5 minutes. After the above program is completed, centrifuge briefly and take out the reverse transcribed cDNA mixture and cool it on ice.

[0049] ②Quantitative PCR detection system:

[0050] Preparation of reaction solution: Prepare the reaction solution on ice. Perform duplicate well experiments and single-well NTC experiments for each sample. Use a white quantitative plate for quantitative PCR detection.

[0051] The reaction solution in each single well of the quantitative plate is configured as follows:

[0052]

[0053]

[0054] A total of 20 μL reaction system.

[0055] qRT-PCR reaction conditions:

[0056] After the reaction solution is fully mixed, centrifuge it to make the reaction solution reach the bottom of the reaction tube and place it on the real-time fluorescence quantitative PCR instrument. The specific reaction design procedure is as follows:

[0057] Pre-denaturation: 60s at 95℃

[0058] Denaturation: 95℃ for 10s

[0059] Annealing: 20s at 61°C

[0060] Extension: 15s at 72℃

[0061] The denaturation to annealing steps were repeated 35 times.

[0062] After the reaction is completed, a melting curve is drawn. In this experiment, the fluorescence detection temperature range is 65°C-95°C, the heating rate is 0.5°C / cycle, and the constant temperature time is 10s / cycle.

[0063] After all reactions were completed, the tubes were kept at 37°C for 30 seconds to prevent them from being burned when being taken out.

[0064] Table 1 Primer sequences for HNRNPAB real-time quantitative PCR

[0065]

[0066] Extract the protein of the proliferating and differentiated bovine skeletal muscle satellite cells. The extraction steps are as follows: discard the culture medium, add pre-cooled PBS to wash the cells. Taking a 6-well plate as an example, add 200 μL of RIPA lysis buffer containing 1% PMSF to each well of the bovine skeletal muscle satellite cells, the dilution ratio is 100:1, lyse at 4°C for 15 minutes, and collect into a 1.5mL enzyme-free centrifuge tube. Under 4°C conditions, high-speed centrifuge 12000×g10min, transfer the supernatant to a 1.5mL enzyme-free centrifuge tube, and store the protein sample at -20°C. The protein concentration was measured by the BCA method, and the protein was diluted with 4× protein loading buffer to ensure that the protein loading amount of all samples was the same, and denatured in boiling water at 100°C for 10 minutes. Then perform Western blot detection, configure 10% concentrated gel and separation gel, then spot, electrophoresis at 80V constant voltage for 40 minutes, and after the protein reaches the separation gel, electrophoresis at 120V constant voltage for 90 minutes. The concentrated gel was removed, and the gel was clamped to the PVDF membrane. The membrane was transferred at a constant current of 300 mA for 2 hours. After the transfer, it was blocked with 5% skim milk powder for 2 hours. The membrane was washed with TBST 3 times, 10 minutes each time. The final dilution of the HNRNPAB primary antibody was 1:500, and the final dilution of the MyHC, MyoG, and Pax7 primary antibodies was 0.5μg / mL; the dilution of the Tubulin primary antibody was 1:3000. The membrane and the primary antibody were sealed in the hybridization bag and incubated overnight at 4°C. The membrane was washed with TBST 3 times, 10 minutes each time. The dilution multiples of the goat anti-mouse secondary antibody and the goat anti-rabbit secondary antibody were 1:20000, and the PVDF was incubated in the secondary antibody diluent at room temperature for 1 hour. The membrane was washed with TBST 3 times, 10 minutes each time. Add 200μL of ECL supersensitive luminescent solution to the PVDF membrane and use ChemiDoc TM Imaging System imaging and storage.

[0067] The results of quantitative PCR and Western blot are shown in Figure 1 The experimental results showed that with the extension of the differentiation time of bovine skeletal muscle satellite cells, the mRNA expression level of HNRNPAB showed a trend of first increasing and then decreasing, and the mRNA expression level of HNRNPAB reached a peak of 2.06 on the first day of induced differentiation. The protein level expression level of HNRNPAB in the differentiation period decreased by 2.4 times compared with that in the proliferation period (before differentiation), indicating that HNRNPAB may have the function of regulating the myogenic differentiation of bovine skeletal muscle satellite cells.

[0068] Step 2: Establishment of bovine skeletal muscle satellite cell inhibition expression model and detection of interference effect:

[0069] According to the base sequence of HNRNPAB, siRNA was designed and synthesized, and then transfected into bovine skeletal muscle satellite cells. The expression level of HNRNPAB was detected by quantitative PCR, and the interference effect of siRNA on HNRNPAB was detected.

[0070] The specific steps are as follows:

[0071] (1) Design and synthesis of HNRNPAB interfering RNA (siRNA).

[0072] Based on the HNRNPAB base sequence, siRNA (SEQ ID NO. 2: CCAAAGAGGTTTATCAACA) was designed and synthesized by a biological company.

[0073] (2) Establishment of an inhibitory expression model of bovine skeletal muscle satellite cells.

[0074] HNRNPAB siRNA was transfected into bovine skeletal muscle satellite cells using lip 3000 reagent. Bovine skeletal muscle satellite cells were inoculated in 24-well cell culture plates and 6-well cell culture plates, respectively, and cultured with growth medium. When the cell growth density was 70% to 80%, transfection was prepared, and the medium was replaced with antibiotic-free growth medium one day before transfection. According to the concentration recommended in the reagent manual, si-RNA and negative control were transfected at a final concentration of 50nM. When performing transfection, first replace the culture medium with serum-free Opti-MEM culture medium. Taking a 24-well plate as an example, mix si-RNA or the corresponding negative control in 50 μL Opti-MEM culture medium, and mix 0.75 μL lip3000 transfection reagent in 50 μL Opti-MEM culture medium. Let them stand for 5 minutes respectively. Add the Opti-MEM culture medium containing siRNA or the corresponding negative control to the Opti-MEM culture medium containing Roche transfection reagent. After gently mixing, let the mixture stand for 15 minutes. Evenly add the mixture dropwise to the 24-well cell culture plate and the 6-well cell culture plate. The volume of the added mixture should be based on the final concentration of siRNA or the corresponding negative control.

[0075] (3) siRNA interference effect detection

[0076] 24 hours after transfection, the culture medium was replaced with myogenic differentiation medium and culture was continued to induce differentiation of muscle satellite cells. After 24 hours and 72 hours of induction differentiation, the total RNA of the transfected cells in the 24-well plate was extracted using a cell RNA rapid extraction kit, and the mRNA expression level of HNRNPAB was detected by quantitative PCR. The total RNA extraction, RNA reverse transcription and quantitative PCR operations were the same as in the first step. The primer sequences used are shown in Table 1. The total protein in the 6-well plate was extracted, and the protein expression level of HNRNPAB was detected by Western blot. The test results are shown in Figure 2 , Figure 3The experimental results showed that siRNA had a significant interference effect on the expression of HNRNPAB, and significantly reduced the expression level of HNRNPAB (**, p<0.01 compared with the control NC), which can be used for subsequent research on the expression regulation of HNRNPAB.

[0077] Step 3: Effect of interfering with HNRNPAB on myogenic differentiation of bovine skeletal muscle satellite cells:

[0078] Bovine skeletal muscle satellite cells were transfected with siRNA to interfere with the expression of HNRNPAB, and then the muscle satellite cells were induced to differentiate into myogenic cells. The expression of differentiation marker genes MyoG and MyHC was tested by quantitative PCR and Western blot, and the effect of interfering with HNRNPAB expression on the myogenic differentiation of bovine muscle satellite cells was determined based on the formation status of myotubes.

[0079] The specific steps are:

[0080] HNRNPAB siRNA was transfected into bovine skeletal muscle satellite cells using lip3000 reagent, and the specific operation was the same as the siRNA transfection method in the second step. 24 hours after transfection, the culture medium was replaced with myogenic differentiation medium and culture was continued to induce differentiation of muscle satellite cells. Quantitative PCR was used to test the mRNA expression of differentiation marker genes MyoG and MyHC. The primer sequences used are shown in Table 2. GAPDH was used as an internal reference, and the sequence was the same as Table 1. The results showed that after interfering with HNRNPAB, the mRNA expression levels of differentiation marker factors MyoG and MyHC on the first day of differentiation (DM1) and the third day of differentiation (DM3) were extremely significantly increased. The test results are shown in Figure 2 (**, p<0.01 compared to control NC).

[0081] Table 2 Primer sequences for real-time quantitative PCR of differentiation marker genes MyoG and MyHC

[0082]

[0083] Western blot was used to test the protein expression of differentiation marker genes MyoG and MyHC. The results showed that after interfering with HNRNPAB, the protein expression levels of differentiation marker factors MyoG and MyHC on the third day of differentiation (DM3) were significantly increased. The test results are shown in Figure 3 (*, compared with the control NC, p<0.05), indicating that downregulation of HNRNPAB can promote the myogenic differentiation of muscle satellite cells. At the same time, the effect of interfering with HNRNPAB expression on the myogenic differentiation of bovine muscle satellite cells was determined by the formation of myotubes. The results are shown in Figure 4Compared with the control group (siRNA-NC), the myotubes formed by the siRNA-transfected muscle satellite cells after differentiation were significantly thicker and the differentiation state was more obvious. The above research results suggest that changing the expression of HNRNPAB related to muscle development and differentiation in bovine skeletal muscle satellite cells can affect the myogenic differentiation process of bovine skeletal muscle satellite cells.

[0084] Of course, methods for changing the expression level of HNRNPAB include designing synthetic interfering RNA (siRNA), as well as plasmids, viral vectors, gene knockout and other means capable of changing the expression level of HNRNPAB that interfere with the expression of HNRNPAB.

[0085] Although the embodiments of the present invention are disclosed for illustrative purposes, those skilled in the art will appreciate that various substitutions, changes and modifications are possible without departing from the spirit and scope of the present invention and the appended claims. Therefore, the scope of the present invention is not limited to the contents disclosed in the embodiments.

Claims

1. A method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression, characterized in that: The method is to promote the myogenic differentiation of bovine skeletal muscle satellite cells by reducing the expression of HNRNPAB; wherein the nucleotide sequence of the HNRNPAB gene is: SEQ ID NO.1, and the method is not intended for the diagnosis and treatment of diseases.

2. The method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression according to claim 1, characterized in that: The steps include: According to the genomic base sequence of HNRNPAB, siRNA of HNRNPAB was designed and synthesized, and bovine skeletal muscle satellite cells were transfected with siRNA to reduce the expression level of HNRNPAB, thereby promoting the myogenic differentiation of bovine skeletal muscle satellite cells.

3. The method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression according to claim 2, characterized in that: The gene sequence of the siRNA is: SEQ ID NO.

2.

4. Use of the method for promoting myogenic differentiation of bovine skeletal muscle satellite cells by interfering with HNRNPAB expression as claimed in any one of claims 1 to 3 in the proliferation and myogenic differentiation of bovine muscle satellite cells, wherein the use is not for the purpose of diagnosis and treatment of diseases.